-
-
-
-
-
-
-
STAAR Surgical reports preliminary Q1 sales exceeding $90 million
-
-
-
-
-
-
-
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
-
-
-
-
-
-
-
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
-
-
-
-
-
-
-
STAAR Surgical Announces Amendments to Alcon Merger Agreement
-
-
-
-
-
-
-
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
-
-
-
-
-
-
-
ISS joins other advisors opposing STAAR-Alcon deal
-
-
-
-
-
-
-
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

